Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents

E-ISSN： 1875-5607|16|15|1219-1229

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.16, Iss.15, 2016-09, pp. : 1219-1229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors: discovery and development as anticancer agents

By Marks Paul A Dokmanovic Milos

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1497-1511

Informa Healthcare

Access to resources Recommend Favorite

Topoisomerase inhibitors as anticancer agents: a patent update

By Khadka Daulat B Cho Won-Jea

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1033-1056

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives

By Kim TaeHun Keum Gyochang Pae Ae Nim

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 919-943

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite